Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody

Mucin1 (MUC1) is abnormally glycosylated and overexpressed in a variety of epithelial cancers and plays a critical role in tumor progression. MUC1 has received remark attention as an oncogenic molecule and is considered a valuable tumor target for immunotherapy, while many monoclonal antibodies (mAb...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Jun, Lai, Shifa, Yu, Haoyang, Ma, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366937/
https://www.ncbi.nlm.nih.gov/pubmed/37489369
http://dx.doi.org/10.3390/antib12030047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366937/
https://www.ncbi.nlm.nih.gov/pubmed/37489369
http://dx.doi.org/10.3390/antib12030047

Ejemplares similares